ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.608C>A (p.Thr203Asn) (rs398122547)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000509879 SCV000608010 uncertain significance Hereditary cancer-predisposing syndrome 2018-03-01 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence
Color RCV000509879 SCV000905901 uncertain significance Hereditary cancer-predisposing syndrome 2018-06-07 criteria provided, single submitter clinical testing
GeneDx RCV000758918 SCV000567749 uncertain significance not provided 2018-08-24 criteria provided, single submitter clinical testing This variant is denoted BRCA2 c.608C>A at the cDNA level, p.Thr203Asn (T203N) at the protein level, and results in the change of a Threonine to an Asparagine (ACC>AAC). Using alternate nomenclature, this variant would be defined as BRCA2 836C>A. This variant has not, to our knowledge, been published in the literature as a pathogenic or benign germline variant. BRCA2 Thr203Asn was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is not located in a known functional domain. In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether BRCA2 Thr203Asn is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Invitae RCV000471187 SCV000549867 uncertain significance Hereditary breast and ovarian cancer syndrome 2018-10-11 criteria provided, single submitter clinical testing This sequence change replaces threonine with asparagine at codon 203 of the BRCA2 protein (p.Thr203Asn). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and asparagine. This variant is present in population databases (rs398122547, ExAC 0.001%) but has not been reported in the literature in individuals with a BRCA2-related disease. ClinVar contains an entry for this variant (Variation ID: 91437). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, this variant is a rare missense change with uncertain impact on protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000758918 SCV000887864 uncertain significance not provided 2017-12-26 criteria provided, single submitter clinical testing
Sharing Clinical Reports Project (SCRP) RCV000076954 SCV000108751 uncertain significance Breast-ovarian cancer, familial 2 2012-09-04 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.